Endopeptidase cleavage of anti-glomerular basement membrane antibodies in vivo in severe kidney disease : an open-label phase 2a study

author
Szpirt, Wladimir
Kronbichler, Andreas
Bruchfeld, Annette
Rostaing, Lionel
Daugas, Eric
Lionet, Arnaud
Kamar, Nassim
Rafat, Cedric
statement of authorship
Fredrik Uhlin, Wladimir Szpirt, Andreas Kronbichler, Annette Bruchfeld, Inga Soveri, Lionel Rostaing, Eric Daugas, Arnaud Lionet, Nassim Kamar, Cédric Rafat, Marek Mysliveček, Vladimír Tesař, Anders Fernström, Christian Kjellman, Charlotte Elfving, Stephen McAdoo, Johan Mölne, Ingeborg Bajema, Elisabeth Sonesson, Mårten Segelmark
source
Journal of the American Society of Nephrology
publisher
The American Society of Nephrology
journal volume number month
vol. 33, 4
year of publication
pages
p. 829-838
subject term
endopeptidaasid
Goodpasture'i sündroom
keyword
Goodpasture syndrome
clinical trial
endopeptidases
glomerulonephritis
ISSN
1046-6673
1533-3450
notes
Bibliogr.: 27 ref
Open Access
Open Access
scientific publication
teaduspublikatsioon
classifier
1.1
category (general)
category (sub)
kvartiil
Q1
language
inglise
Uhlin, F., Szpirt, W., Kronbichler, A., Bruchfeld, A., Soveri, I., Rostaing, L., Daugas, E., Lionet, A., Kamar, N., Rafat, C. et. al. Endopeptidase cleavage of anti-glomerular basement membrane antibodies in vivo in severe kidney disease : an open-label phase 2a study // Journal of the American Society of Nephrology (2022) vol. 33, 4, p. 829-838. https://doi.org/10.1681/ASN.2021111460